InnoCare Announces Company Secretary Transition Effective 25 March 2026

Bulletin Express
03/25

InnoCare Pharma Limited (InnoCare) has disclosed a forthcoming change in its senior corporate governance roles.

Ms. Lee Angel Pui Shan has tendered her resignation as Company Secretary, Authorised Representative under Listing Rule 3.05, and Process Agent under Part 16 of the Hong Kong Companies Ordinance. Her duties will conclude on 25 March 2026. According to the filing, Ms. Lee confirmed no disagreements with the Board and no matters requiring shareholder or Stock Exchange attention.

Effective the same date, Ms. Lin Sio Ngo will assume all three positions. Ms. Lin, currently a manager at SWCS Corporate Services Group (Hong Kong) Limited, brings more than 20 years of experience in corporate secretarial and administrative management. She has been an associate member of The Hong Kong Chartered Governance Institute and The Chartered Governance Institute since 2004, and holds both a bachelor’s degree in business administration and a master’s degree in corporate governance.

The Board expressed its gratitude to Ms. Lee for her service and welcomed Ms. Lin to her new roles.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10